Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential merits of including people with post-Covid syndrome in the list of people qualified for an autumn booster vaccine.

The Government is committed to protecting those most vulnerable to COVID-19 through vaccination, as guided by the independent Joint Committee on Vaccination and Immunisation (JCVI). The JCVI stated in its advice for the autumn 2024 COVID-19 vaccination programme that there remains considerable uncertainty regarding the impact of additional vaccine doses, beyond the primary vaccination, on the risk, progression, and outcome of post-COVID syndromes. The JCVI advised that better data is needed on the impact of additional vaccine doses on the occurrence and severity of post-COVID syndromes in the current era of Omicron sub-variants of the COVID-19 virus, and high population immunity. This advice is available at the following link:

https://www.gov.uk/government/publications/covid-19-autumn-2024-vaccination-programme-jcvi-advice-8-april-2024/jcvi-statement-on-the-covid-19-vaccination-programme-for-autumn-2024-8-april-2024

On 13 November 2024, the JCVI published advice on the COVID-19 vaccination programme in spring 2025, autumn 2025 and spring 2026. This advice is available at the following link:

https://www.gov.uk/government/publications/covid-19-vaccination-in-2025-and-spring-2026-jcvi-advice/jcvi-statement-on-covid-19-vaccination-in-2025-and-spring-2026#:~:text=the%20JCVI%20webpage.-,Advice%20on%20vaccination%20in%20spring%202025,care%20home%20for%20older%20adults

The Government has accepted the JCVI’s advice on eligibility for the spring 2025 COVID-19 vaccination programme. The Government is considering the advice for autumn 2025 and spring 2026 carefully, and will respond in due course.